Junshi Biotechnology and Deqi Pharmaceuticals have reached a strategic cooperation.

On February 25th, Kunshe Biological announced a strategic partnership with Deqi Pharmaceuticals. The two parties will jointly explore the synergistic potential of Kunshe Biological's independently developed JS207 and Deqi Pharmaceuticals' ATG-037 in the combined treatment of cancer patients in mainland China.